Pharma major Dr Reddy's Laboratories has signed a global distribution agreement with Albermarie Corporation, a US-based specialty chemicals company, for ibuprofen active pharmaceutical ingredient.


</p><tr><td><p class='TableClas'></p><P class='TableClas'><DIV CLASS=rightDiv><script language="JavaScript">
		google_ad_client = 'businessstandard';
		//google_ad_client = 'ca-businessstandard_js';
		google_ad_width = 200;
		google_ad_height = 200;
		google_ad_format = "200x200_as";
		google_ad_type = "text";
		google_ad_channel = "";
		//google_color_border = "FFFFFF";
		google_color_border = "F7F7F7";
		//google_color_bg = "FFFFFF";
		google_color_bg = "ffffff";
		//google_color_link = "639ACE";
		google_color_link = "0253B7";
		google_color_text = "000000";
		google_color_url = "D63431";
		//google_skip = adsenseSkip;
		</script> 
		<script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
		</script> </DIV><p class='TableClas'>According to the agreement, Albermarie will supply ibuprofen API from its Orangeburg plant in South Carolina to Dr Reddy's for distribution to its global client base. Further terms of the agreement were not disclosed. </P>
</p><p class='TableClas'>Ibuprofen is used for management of pain, fever and inflammation. Its market size is estimated at $2.24 billion globally, a release said.</P></p><p class='TableClas'></p></table>


Dr Reddy's signs distribution pact with Albermarie

More From This Section

Posco land acquisition resumes amid protests

Diageo to buy half of Mallya's South Africa beer biz

Average money spent for new players dips

'IndiGo did not comply with AAC guidelines'

Explore News